Elite Pharma - About the company
Elite Pharma is a public company based in Alhambra (United States), founded in 1998. It operates as a Developer of controlled-release generic and branded pharmaceutical products. Elite Pharma has raised an undisclosed amount in funding.
Company Details
Developer of controlled-release generic and branded pharmaceutical products. This company specializes in the development and manufacture of oral, controlled-release products. Its strategy includes developing generic versions of controlled-release drug products with high barriers to entry. The company also possesses proprietary abuse-deterrent technology for opioid products, applicable across various opioids. A portion of its generic product portfolio is licensed to other pharmaceutical companies. Manufacturing is conducted in a cGMP and DEA registered facility.
Key Metrics
Founded Year
1998
Location
Alhambra, United States
Stage
Public
Latest Funding Round
Annual Revenue
$100M - $500M as on Mar 31, 2026
Employee Count
1 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with Elite Pharma
Elite Pharma is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ELITE PHARMACEUTICALS INC /NV/ CIN: 1053369 , United States, Active | Sep 30, 1997 | $100M - $500M (As on Mar 31, 2026) | 53 (As on Jun 30, 2023) | - |
Elite Pharma's IPO details
Elite Pharma got listed on Jul 24, 1998.
Click here to take a look at Elite Pharma's IPO in detail
Sign up to download Elite Pharma's company profile
Elite Pharma's funding and investors
Elite Pharma has raised funding over 5 rounds. Its first funding round was on Jun 11, 2009.
Here is the list of recent funding rounds of Elite Pharma:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 13, 2020 | 5490274 | Post IPO | 6109155 | 5671880 | 7601072 | 2889923 |
May 10, 2017 | 3833037 | Post IPO | 4056438 | 9159889 | 6777235 | 5384453 |
Apr 15, 2014 | 8443207 | Post IPO | 4236749 | 7282753 | 1661854 | 9290963 |
View details of Elite Pharma's funding rounds and investors
Elite Pharma's founders and board of directors
Founder? Claim ProfileElite Pharma's employee count trend
Elite Pharma has 1 employees as of Sep 26. Here is Elite Pharma's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Elite Pharma's Investments and acquisitions
Elite Pharma has made no investments or acquisitions yet.
Reports related to Elite Pharma
Here is the latest report on Elite Pharma's geography:
News related to Elite Pharma
Media has covered Elite Pharma for a total of 4 events in the last 1 year, 2 of them have been about company updates.
•
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Informationwallstreet:online•Aug 13, 2026•Elite Pharma
•
Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XLFinanzNachrichten•Aug 04, 2026•Elite Pharma
•
Elite Pharmaceuticals (OTCPK:ELTP) Stock Faces Earnings Quality Questions After TTM Profitability ReachedSimply Wall St•Jul 01, 2026•Elite Pharma
•
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride TabletsNewsfile•Apr 02, 2026•Elite Pharma
•
•
Elite Pharmaceuticals receives FDA approval on its NDA for ADHD treatmentSeeking Alpha•Nov 18, 2024•Elite Pharma
•
•
Elite Pharmaceuticals announces FDA ANDA approval for generic methotrexateSeeking Alpha•May 20, 2024•Elite Pharma
•
Elite Pharmaceuticals Receives FDA Approval for Generic MethotrexateBioSpace•May 20, 2024•Elite Pharma
•
Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System StimulantBioSpace•Dec 26, 2023•Elite Pharma
Are you a Founder ?
FAQs about Elite Pharma
Explore our recently published companies
- Akumentis Healthcare - Thane based, 2010 founded, Series A company
- Braintree Laboratories - Braintree based, 1982 founded, Acquired company
- MG Collision and Auto - Houston based, Unfunded company
- M. B. Auto - New Bedford based, 2022 founded, Unfunded company
- Corona Remedies - Ahmedabad based, 2004 founded, Public company
- Miller Brothers Scratch and Dent - Cape Coral based, Unfunded company